Here are five things to know about the health IT company’s fiscal year 2016 Q3 results.
1. Allscripts’ revenue rose 11 percent between Q3 of FY 2015 and Q3 of FY 2016. It increased to $392.4 million this year, up from $354.5 million in 2015.
2. Revenue was still 5.7 percent below analysts’ predictions. Analysts polled by Thomson Reuters estimated Allscripts’ Q3 revenue would reach $414.9 million.
3. Allscripts’ Q3 per-share earnings also fell below expectations. Excluding stock-based compensation, the company’s Q3 per-share earnings were 14 cents. Analysts predicted per-share earnings of 15 cents.
4. Allscripts’ FY 2016 Q3 bookings were 7 percent higher than its FY 2015 Q3 bookings. This year’s bookings totaled $291 million, compared to the company’s $272 million during the same period last year.
5. Allscripts CEO Paul Black remains positive about the results. “Allscripts continued to drive good sales momentum in the third quarter, adding new clients and growing existing relationships across the company’s large global installed base,” he said.
More articles on health IT:
Cyberattack causes UK-based hospitals to cancel appointments, operations
Survey: 51.4% of patients have received email, texts from a physician
University College London Hospitals selects Epic for EHR system
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
